Haemonetics (HAE) Other Non-Current Liabilities (2010 - 2026)

Haemonetics has reported Other Non-Current Liabilities for 17 years, with the latest figure at $57.2 million in Q2 2026.

• On a quarterly basis, Other Non-Current Liabilities fell 16.01% year-over-year to $57.2 million in Q2 2026; TTM through Jun 2026 was $57.2 million, a 16.01% decrease from a year earlier, with the FY2026 full-year figure at $59.4 million, down 12.91% from the prior year.
• Other Non-Current Liabilities was $57.2 million for Q2 2026 at Haemonetics, down from $59.4 million in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $92.3 million in Q2 2024, with the low at $57.2 million in Q2 2026.
• Average Other Non-Current Liabilities over 5 years is $74.7 million, with a median of $74.7 million recorded in 2023.
• The sharpest annual moves came in 2024 and 2025: Other Non-Current Liabilities advanced 28.71% in 2024, then decreased 29.3% in 2025.
• Over 5 years, Other Non-Current Liabilities stood at $78.2 million in 2022, then retreated by 2.51% to $76.3 million in 2023, then gained by 17.97% to $90.0 million in 2024, then fell by 29.3% to $63.6 million in 2025, then fell by 10.12% to $57.2 million in 2026.
• The last three Other Non-Current Liabilities figures came in at $57.2 million (Q2 2026), $59.4 million (Q1 2026), and $63.6 million (Q4 2025), per Business Quant data.